Next Generation IVD Connectivity
The potential to reduce the cost and time involved with lab device connectivity has been demonstrated with the IHE LAW Profile. As an industry, it’s time we move beyond our interoperability challenges and refocus our energy on advancing healthcare.
Eric Olson, President, IICC, and Vice President, Portfolio & Product Management, Siemens Healthcare Diagnostics, Inc.
The publication of the LAW Profile as a supplement for trial implementation and the successful completion of the IHE European Connectathon 2012 are important milestones. The next step is implementation in the coming generation of IVD products, which will integrate the clinical lab into the mainstream of healthcare information flow.
Edwin O. Heierman, Chief Technology Officer, IICC, and Informatics Software Architect, Abbott Diagnostics Division
Over the next 5 years, Meaningful Use will have a huge impact on the IVD world, and all stakeholders will benefit—especially the patients. Now is the time to act. We want to drive the change, not just sit back and let change drive us.
Jay B. Jones, PhD, DABCC, Board Member and Chair of the Provider Review Committee, IICC, and Director, Chemistry & Regional Labs, Geisinger Health System